Activist hedge fund Elliott Management is calling on GlaxoSmithKline plc to listen to offers for its Consumer Healthcare business as an alternative to its plan to spin-off and list the business on the London Stock Exchange next year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?